< Back to latest news & events

News

SkyKick ruling

January 2020

Specification of trade marks must be consistent with the essential function of indicating origin of the goods and services or risk being partially invalid for bad faith.

Case C-371/18 – Sky plc & ors v SkyKick UK Ltd & anor, 29 January 2019

Two days before the UK’s departure from the EU, the CJEU handed down its eagerly anticipated Judgment in SkyKick finding that a trade mark application made without any intention to use the trade mark in relation to the goods and services in the specification does constitute bad faith.  This was the case if the applicant had the intention either of undermining, in a manner inconsistent with honest practices, the interests of third parties, or of obtaining, without even targeting a specific third party, an exclusive right for purposes other than those falling within the functions of a trade mark.  However, this aspect of bad faith does not invalidate the entire trade mark (i.e., the “poisoned well”) but only the goods and services shown to have been applied for in bad faith.  The CJEU also indicated that it was permissible for national law to contain procedural requirements for an applicant to make a statement that he or she has bona fide intention to use a trade mark.  Such statements might be utilised as evidence in claims of bad faith but did not constitute a separate ground of invalidity.

The CJEU also held that a lack of clarity and precision of terms used to designate the goods or services (e.g., “computer software”) was not grounds for invalidity.  Furthermore, a trade mark cannot be declared wholly or partially invalid on the ground that terms used to designate the goods and services in respect of which that trade mark was registered lack clarity and precision.

Background

The case was referred by the UK High Court in an action where Sky plc (the broadcaster) claimed that SkyKick (at the time, a start-up company that supplied cloud migration information technology services) had infringed four EU trade marks and one UK trade mark consisting of the word SKY through use of the sign ‘SkyKick’ and variants thereof.  SkyKick denied infringement and counterclaimed for a declaration that the trade marks were invalidly registered, in whole or in part, on the grounds that: (i) the specifications of goods and services lacked clarity and precision and (ii) the applications were made in bad faith.  The claim in bad faith was based on the allegation that while Sky plc did intend to use for some of the goods and services in the specification, that had not intended to use the trade marks in relation to all of the goods and services specified.   SkyKick’s primary case was that the trade marks were invalid in their entirety (the “poisoned well” argument).  In the alternative, that the trade marks were partially invalid where Sky plc had not had any intention to use the trade marks.

Arnold J (as he was then) noted that SkyKick did not appear to have a defence to Sky plc’s claims for trade mark infringement despite the fact that the marks had not been used, and were not likely to be used, for many of the goods and services in respect of which they were registered.

Conclusions

This Judgment has far-reaching implications for, in particular, companies with trade mark portfolios containing multiple, broad trade mark filings in the EU.  The practice of filing extensively across multiple classes of goods and services and then “evergreening” such filings to avoid scrutiny for non-use are now likely to be critically examined by intellectual property offices and national courts.  Very few companies are likely to have a commercial justification for applying for trade marks with broad specifications across multiple classes.  Many will have already considered their portfolios following the AG’s opinion in October 2019 and will breathe a sigh of relief that the CJEU has confirmed that this type of bad faith will only partially invalidate the trade mark.  However, trade mark owners would be wise to consider the impact of the Judgment on their existing portfolios and filing practices.

This update was prepared by HGF Partner Rachel Fetches.  If you would like further advice on this or any other matter, please contact Rachel.  Alternatively, you can contact your usual HGF representative or visit our Contact page to get in touch with your nearest HGF office.

Latest updates

Agritech Thymes: The Bite of Implied Consent: Lessons from the Pink Lady Case

Can the supply of a plant variety without clear and defined restrictions on its use be an implicit consent to commercialise it? This case centres on the evidence required to …

Read article

IAM Global Leaders 2026

HGF is proud to announce that we have 3 partners listed as an IAM Global Leader 2026. To qualify for inclusion in the IAM Global Leaders, individuals must be ranked …

Read article

The Bite of Implied Consent: Lessons from the Pink Lady Case

A recent European Union court decision considers the issue of implied consent to commercialise a plant variety, and whether the evidence meets the threshold of “serious doubts” of the validity …

Read article
Event - 5th November 2025

HGF are Gold Sponsors of IAM Live: Navigating the UPC 2025

We’re excited to share that HGF is a Gold Sponsor of IAM Live: Navigating the UPC 2025, taking place on the 5th November at the Marriott Opera Ambassador Hotel in …

Event details

HGF ranked band 1 in Chambers and Partners UK 2026

The Chambers and Partners UK 2026 Guide is now live and HGF has one again been highly ranked as a firm, with several recognised individuals across multiple regions. HGF is …

Read article

How France's investment in digital health, AI, and bioinformatics is transforming the intellectual property (IP) landscape

In recent years, France has become a key player in digital health innovation, driven by strategic government investments under the France 2030 initiative and the French Tech 2030 program. These …

Read article
Event - 14th October 2025

The Future of Protein Production Amsterdam 2025

HGF are proud to be sponsoring the Future of Protein Production Amsterdam 2025, the leading global event bringing together innovators across fermentation, cultivated and plant-based proteins. Date: 29-30th October 2025  …

Event details

A Turning Point for AI Patent Eligibility?

Director Squires Vacates PTAB § 101 Rejection in DeepMind Case In a notable early move as Under Secretary of Commerce and USPTO Director, John Squires has vacated a Patent Trial …

Read article